510(k) Report

510(k) · Cleared

Cleared

Stellaris Elite vision enhancement system (BL11145, BL14455, BL15455)

K240169510(k) TraditionalCleared Jul 26, 2024186-day reviewClass II21 CFR 886.4670

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bausch and Lomb, Incorporated · HQC Unit, Phacofragmentation

Cleared on Jul 26, 2024 after a 186-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 1 later device descends from it.

Decided
Jul 26, 2024
Review
186 days
Class
Class II
Product code
HQC
Recalls
None
Predicates
0

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2026: 1 descendant cleared2020202220242026
  1. This deviceK240169 Stellaris Elite vision enhancement system (BL11145, BL14455, BL15455)Bausch and Lomb, Incorporated · 2024
  2. Descendant · cites it directly · 0 of its ownK252052 Stellaris Elite™ vision enhancement system (BL11145, BL14455…Bausch and Lomb, Incorporated · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K252052Stellaris Elite™ vision enhancement system (BL11145, BL14455, BL15455, SE14565, SE15565…Bausch and Lomb, Incorporated · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K240169Stellaris Elite vision enhancement system (BL11145, BL14455, BL15455)Bausch and Lomb, Incorporated2024—
+1K252052Stellaris Elite™ vision enhancement system (BL11145, BL14455, BL15455…Bausch and Lomb, Incorporated2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K240169, 2024–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HQC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HQC device

  1. #1 K261264 Stellaris Elite™ vision enhancement system…score 13.4 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K252052Stellaris Elite™ vision enhancement system (BL11145, BL14455, BL15455, SE14565, SE15565…Bausch and Lomb, Incorporated20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K252052 (Bausch and Lomb, Incorporated, 2026) has gone furthest, with 0 descendants of its own.

How does its category compare?

All HQC devices

HQC Unit, Phacofragmentation: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · HQC

3in 2025

2008: 42009: 52010: 32011: 52012: 52014: 42015: 32016: 12017: 32019: 42020: 42021: 12022: 42023: 12024: 52025: 32026 (partial year): 3
2007high 5 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HQC

267in 2025

2008: 162 days median2009: 131 days median2010: 142 days median2011: 129 days median2012: 125 days median2014: 135 days median2015: 124 days median2017: 214 days median2019: 126 days median2020: 227 days median2022: 245 days median2024: 197 days median2025: 267 days median2026 (partial year): 115 days median
2007high 267 (2025) · low 124 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HQC

1in 2025

2008: 12009: 12010: 222011: 42012: 12014: 12018: 22022: 52023: 12025: 1
2007high 22 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HQC

1,799in 2025

2007: 3412008: 4442009: 5402010: 2,4312011: 1,8022012: 2,2772013: 2,7722014: 2,7402015: 3,3552016: 3,3742017: 2,7812018: 2,4162019: 2,2872020: 1,2172021: 1,6732022: 1,9072023: 1,7992024: 2,1202025: 1,799
2007high 3,374 (2016) · low 341 (2007)2025

MAUDE reports naming product code HQC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—0341
200841621444
200951311540
20103142222,431
2011512941,802
2012512512,277
20130—02,772
2014413512,740
2015312403,355
20161—03,374
2017321402,781
20180—22,416
2019412602,287
2020422701,217
20211—01,673
2022424551,907
20231—11,799
2024519702,120
2025326711,799
202631150—
Cite this page

510(k) Report. “K240169: Stellaris Elite vision enhancement system (BL11145, BL14455, BL15455).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K240169

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026